Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25- epi ritterostatin G N 1 N

Volume: 126, Pages: 74 - 78
Published: Oct 1, 2017
Abstract
Cephalostatins, ritterazines and their hybrid bis-steroidal pyrazine analogs such as 25-epi-rittereostatin GN1N show unusually high potency against a wide range of cancer cell lines. Herein, we report the synthesis and bioactivity of 23-deoxy-25-epi ritterostatin GN1N, which lacks the 23-hydroxyl group of 25-epi rittereostatin GN1N. The less oxygenated bis-steroidal pyrazine was ∼50- to 1000-fold less potent than 25-epi ritterostatin GN1N,...
Paper Details
Title
Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25- epi ritterostatin G N 1 N
Published Date
Oct 1, 2017
Journal
Volume
126
Pages
74 - 78
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.